Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BRISTOL MYERS SQUIBB COBMY · Entity 1662 | Director | September 30, 2026 | October 03, 2026 |
| GE HealthCare Technologies Inc.GEHC · Entity 1711 | Director · President and CEO | September 03, 2026 | September 04, 2026 |
| GENERAL ELECTRIC COGE · Entity 2813 | Senior Vice President | March 01, 2022 | March 04, 2022 |
| INTEGRA LIFESCIENCES HOLDINGS CORPIART · Entity 2707 | Director · President & CEO | September 02, 2021 | September 07, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BRISTOL MYERS SQUIBB CO
Report date September 30, 2026 · Filed October 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 74,077.176 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 560.897 · Balance 74,077.176 F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.
F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.
GE HealthCare Technologies Inc.
Report date September 03, 2026 · Filed September 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.01 per shareSEC Table I · non-derivative | Direct | 241,606 |
Reported balance
After 2026-09-03 transaction · row 1
1 source rowRow 1 · 2026-09-03 · Tax withholding · Disposed 6,303 · Balance 241,606 F1: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
GENERAL ELECTRIC CO
Report date March 01, 2022 · Filed March 04, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 14,443 |
Reported balance
After 2022-03-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-03-01 · Grant · Acquired 14,443 · Balance 14,443 F1: 1 for 1 F2: The Restricted Stock Units vest and the Stock Options become exercisable, in two equal installments of 50% each on the second and third anniversary of the grant date |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $92.23 · Expires 2032-03-01 | Direct | 63,044 |
Reported balance
After 2022-03-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-01 · Grant · Acquired 63,044 · Balance 63,044 F2: The Restricted Stock Units vest and the Stock Options become exercisable, in two equal installments of 50% each on the second and third anniversary of the grant date |
Filing footnotes · ownership attribution and instrument terms
F1: 1 for 1
F2: The Restricted Stock Units vest and the Stock Options become exercisable, in two equal installments of 50% each on the second and third anniversary of the grant date
INTEGRA LIFESCIENCES HOLDINGS CORP
Report date September 02, 2021 · Filed September 07, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 216,713 |
Ending reported balance
After 2021-09-03 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2021-09-02 · Exercise / conversion · Acquired 71,829 · Balance 288,542 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Row 2 · 2021-09-02 · Sale · Disposed 71,829 · Balance 216,713 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F2: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $75.34 to $76.465 per share of common stock. Row 3 · 2021-09-03 · Exercise / conversion · Acquired 46,605 · Balance 263,318 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. Row 4 · 2021-09-03 · Sale · Disposed 46,605 · Balance 216,713 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F3: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $75.40 to $76.09 per share of common stock. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.88 · Expires 2022-03-06 | Direct | 46,605 |
Reported balance
After 2021-09-02 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-09-02 · Exercise / conversion · Disposed 71,829 · Balance 46,605 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F4: One-third of the stock options vested on the first anniversary of the grant date of March 6, 2014 and thereafter with respect to the remaining two-thirds which vested in monthly installments through the third anniversary of the grant date. F5: These options were previously reported as covering 56,727 shares at an exercise price of $48.27 per share, but were adjusted pursuant to the anti-dilution provisions of the award in connection with the separation of SeaSpine Holdings Corporation on July 1, 2015. F6: In accordance with terms of the stock option plan, the exercise price of the options and the number of shares subject to the options have been adjusted to reflect the two-for-one stock split of the Issuer's common stock that occurred on December 21, 2016. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $20.88 · Expires 2022-03-06 | Direct | 0 |
Reported balance
After 2021-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-09-03 · Exercise / conversion · Disposed 46,605 · Balance 0 F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person. F4: One-third of the stock options vested on the first anniversary of the grant date of March 6, 2014 and thereafter with respect to the remaining two-thirds which vested in monthly installments through the third anniversary of the grant date. F5: These options were previously reported as covering 56,727 shares at an exercise price of $48.27 per share, but were adjusted pursuant to the anti-dilution provisions of the award in connection with the separation of SeaSpine Holdings Corporation on July 1, 2015. F6: In accordance with terms of the stock option plan, the exercise price of the options and the number of shares subject to the options have been adjusted to reflect the two-for-one stock split of the Issuer's common stock that occurred on December 21, 2016. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F2: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $75.34 to $76.465 per share of common stock.
F3: The price shown above represents the weighted average price of the shares sold. The range of sale prices was $75.40 to $76.09 per share of common stock.
F4: One-third of the stock options vested on the first anniversary of the grant date of March 6, 2014 and thereafter with respect to the remaining two-thirds which vested in monthly installments through the third anniversary of the grant date.
F5: These options were previously reported as covering 56,727 shares at an exercise price of $48.27 per share, but were adjusted pursuant to the anti-dilution provisions of the award in connection with the separation of SeaSpine Holdings Corporation on July 1, 2015.
F6: In accordance with terms of the stock option plan, the exercise price of the options and the number of shares subject to the options have been adjusted to reflect the two-for-one stock split of the Issuer's common stock that occurred on December 21, 2016.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 3, 2026 00:22 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 560.897 | $62.40 | $34,999.97 |
DisclosureSEC source: 0001323134-26-000024 · wk-form4_1790972525.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,077.176 Underlying: Common Stock, $0.10 par value · 560.897 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 20:39 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 6,303 | $70.56 | $444,739.68 |
DisclosureSEC source: 0001323134-26-000022 · wk-form4_1788554361.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,606 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 5,472 | $71.23 | $389,770.56 |
DisclosureSEC source: 0001323134-26-000020 · wk-form4_1788466573.xml · nonDerivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,909 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:16 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 6,043 | $71.23 | $430,442.89 |
DisclosureSEC source: 0001323134-26-000020 · wk-form4_1788466573.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,381 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 20:15 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 607.428 | $57.62 | $35,000.00 |
DisclosureSEC source: 0001323134-26-000016 · wk-form4_1783023321.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,815.595 Underlying: Common Stock, $0.10 par value · 607.428 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| April 30, 2026 Filed Apr 30, 2026 20:20 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | PurchaseCommon Stock, par value $0.01 per share | 4,169 | $59.93 | $249,827.33 |
DisclosureSEC source: 0001323134-26-000014 · wk-form4_1777580401.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,424 Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:24 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 577.082 | $60.65 | $35,000.02 |
DisclosureSEC source: 0001323134-26-000012 · wk-form4_1775161441.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,435.166 Underlying: Common Stock, $0.10 par value · 577.082 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:22 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 129,140 | $0.00 Strike: $80.16 | $0.00 |
DisclosureSEC source: 0001323134-26-000010 · wk-form4_1772659337.xml · derivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,140 Underlying: Common Stock, par value $0.01 per share · 129,140 shares Expires 2036-03-02 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:22 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 49,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001323134-26-000010 · wk-form4_1772659337.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,255 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:13 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 33,445 | $79.20 | $2,648,844.00 |
DisclosureSEC source: 0001323134-26-000008 · wk-form4_1771373612.xml · nonDerivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,135 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of PSUs. Read SEC document |
| February 12, 2026 Filed Feb 18, 2026 00:13 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 74,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001323134-26-000008 · wk-form4_1771373612.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,580 F1 · shares: Performance stock units ("PSUs") granted on March 1, 2023, by GE HealthCare Technologies Inc. ("GE HealthCare"). Each PSU represented the right to receive one share of GE HealthCare common stock. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee and the PSUs vested on February 12, 2026. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 23:47 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 3,210 | $78.97 | $253,493.70 |
DisclosureSEC source: 0001323134-26-000006 · wk-form4_1770162439.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,672 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:18 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 3,996.367 | $55.05 | $220,000.00 |
DisclosureSEC source: 0001323134-26-000005 · wk-form4_1770153536.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,858.084 Underlying: Common Stock, $0.10 par value · 3,996.367 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:11 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 625.695 | $0.00 | $0.00 |
DisclosureSEC source: 0001323134-26-000002 · wk-form4_1767647458.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,116.446 Underlying: Common Stock, $0.10 par value · 625.695 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 22:11 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 748.337 | $0.00 | $0.00 |
DisclosureSEC source: 0001323134-25-000007 · wk-form4_1759443057.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,620.164 Underlying: Common Stock, $0.10 par value · 748.337 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:11 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 5,472 | $73.73 | $403,450.56 |
DisclosureSEC source: 0001323134-25-000005 · wk-form4_1756930278.xml · nonDerivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,882 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| September 01, 2025 Filed Sep 3, 2025 20:11 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 5,874 | $73.73 | $433,090.02 |
DisclosureSEC source: 0001323134-25-000005 · wk-form4_1756930278.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,354 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 21:52 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 729.099 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-25-000125 · wk-form4_1751406733.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,988.874 Underlying: Common Stock, $0.10 par value · 729.099 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 21:58 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 553.369 | $60.99 | $33,749.98 |
DisclosureSEC source: 0000014272-25-000077 · wk-form4_1743544699.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,491.287 Underlying: Common Stock, $0.10 par value · 553.369 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:33 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 119,913 | $0.00 Strike: $86.45 | $0.00 |
DisclosureSEC source: 0001628280-25-010692 · wk-form4_1741221203.xml · derivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,913 Underlying: Common Stock, par value $0.01 per share · 119,913 shares Expires 2035-03-03 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 3, 2026, 33% will become exercisable on September 3, 2027, and 34% will become exercisable on September 3, 2028, subject to certain conditions. Read SEC document |
| March 03, 2025 Filed Mar 6, 2025 00:33 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 41,931 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010692 · wk-form4_1741221203.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 179,228 F1 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock. F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 3, 2026, 33% will vest on September 3, 2027, and 34% will vest on September 3, 2028. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:28 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 29,818 | $87.35 | $2,604,602.30 |
DisclosureSEC source: 0001628280-25-009984 · wk-form4_1741127276.xml · nonDerivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,297 F2 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of performance stock units. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 22:28 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 4,507 | $87.35 | $393,686.45 |
DisclosureSEC source: 0001628280-25-009984 · wk-form4_1741127276.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,115 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 06, 2025 Filed Feb 10, 2025 21:56 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 67,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004678 · wk-form4_1739224567.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,622 F1 · shares: Performance stock units ("PSUs") granted on February 23, 2022, by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE HealthCare's Talent, Culture, and Compensation Committee on February 6, 2025. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2025, subject to the reporting person's continued employment. Read SEC document |
| February 01, 2025 Filed Feb 4, 2025 21:19 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 3,206 | $88.30 | $283,089.80 |
DisclosureSEC source: 0001628280-25-003726 · wk-form4_1738703936.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,135 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2025 Filed Feb 5, 2025 00:07 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 3,562.341 | $58.95 | $210,000.00 |
DisclosureSEC source: 0000014272-25-000016 · wk-form4_1738714048.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,937.918 Underlying: Common Stock, $0.10 par value · 3,562.341 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2024 Filed Jan 2, 2025 23:25 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 596.711 | $56.56 | $33,749.97 |
DisclosureSEC source: 0000014272-25-000002 · wk-form4_1735860340.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,788.276 Underlying: Common Stock, $0.10 par value · 596.711 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 21:38 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 652.3 | $51.74 | $33,750.00 |
DisclosureSEC source: 0000014272-24-000131 · wk-form4_1727905078.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,577.675 Underlying: Common Stock, $0.10 par value · 652.3 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 01, 2024 Filed Sep 4, 2024 20:05 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 5,859 | $84.82 | $496,960.38 |
DisclosureSEC source: 0001628280-24-039296 · wk-form4_1725480306.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,341 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| June 30, 2024 Filed Jul 2, 2024 21:20 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 825.659 | $41.53 | $34,289.62 |
DisclosureSEC source: 0000014272-24-000106 · wk-form4_1719955236.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,249.647 Underlying: Common Stock, $0.10 par value · 825.659 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2024 Filed Apr 2, 2024 22:37 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 645.399 | $54.23 | $34,999.99 |
DisclosureSEC source: 0000014272-24-000080 · wk-form4_1712097420.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,708.649 Underlying: Common Stock, $0.10 par value · 645.399 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 103,527 | $0.00 Strike: $92.72 | $0.00 |
DisclosureSEC source: 0001628280-24-009069 · wk-form4_1709679058.xml · derivative · entry 3 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,527 Underlying: Common Stock, par value $0.01 per share · 103,527 shares Expires 2034-03-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2025, 33% will become exercisable on September 1, 2026, and 34% will become exercisable on September 1, 2027, subject to certain conditions. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 36,399 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009069 · wk-form4_1709679058.xml · nonDerivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,200 F2 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 1, 2025, 33% will vest on September 1, 2026, and 34% will vest on September 1, 2027, subject to certain conditions. F3 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:51 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | Tax withholdingCommon Stock, par value $0.01 per share | 4,444 | $91.28 | $405,648.32 |
DisclosureSEC source: 0001628280-24-009069 · wk-form4_1709679058.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,801 F1 · shares: Withholding of shares of GE HealthCare Technologies Inc. ("GE HealthCare") common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 01, 2024 Filed Feb 6, 2024 00:13 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 4,314.773 | $48.67 | $210,000.00 |
DisclosureSEC source: 0000014272-24-000024 · wk-form4_1707178399.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,063.25 Underlying: Common Stock, $0.10 par value · 4,314.773 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 22:31 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 657.767 | $51.31 | $33,750.02 |
DisclosureSEC source: 0000014272-24-000002 · wk-form4_1704321084.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,167 Underlying: Common Stock, $0.10 par value · 657.767 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2023 Filed Oct 3, 2023 22:26 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 581.496 | $58.04 | $33,750.03 |
DisclosureSEC source: 0000014272-23-000159 · wk-form4_1696371998.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,997.95 Underlying: Common Stock, $0.10 par value · 581.496 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 21:28 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 527.756 | $63.95 | $33,750.00 |
DisclosureSEC source: 0000014272-23-000132 · wk-form4_1688592514.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,999.589 Underlying: Common Stock, $0.10 par value · 527.756 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2023 Filed Apr 5, 2023 01:01 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 486.943 | $69.31 | $33,750.02 |
DisclosureSEC source: 0000014272-23-000100 · wf-form4_168065647911412.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,104.299 Underlying: Common Stock, $0.10 par value · 486.943 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 109,994 | Not disclosed Strike: $75.30 | Not disclosed |
DisclosureSEC source: 0001628280-23-006429 · wf-form4_167789114638774.xml · derivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,994 Underlying: Common Stock, par value $0.01 per share · 109,994 shares Expires 2033-03-01 F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 1, 2024, 33% will become exercisable on September 1, 2025, and 34% will become exercisable on September 1, 2026. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:52 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 39,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006429 · wf-form4_167789114638774.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,245 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 23:02 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 188,127 | Not disclosed Strike: $70.01 | Not disclosed |
DisclosureSEC source: 0001628280-23-002266 · wf-form4_167546531200137.xml · derivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,127 Underlying: Common Stock, par value $0.01 per share · 188,127 shares Expires 2033-02-01 F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 23:02 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantCommon Stock, par value $0.01 per share | 21,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-002266 · wf-form4_167546531200137.xml · nonDerivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,820 F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026. F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 21,425 newly awarded restricted stock units and 20,395 previously reported restricted stock units. Read SEC document |
| February 01, 2023 Filed Feb 4, 2023 00:21 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 2,807.806 | $71.23 | $200,000.02 |
DisclosureSEC source: 0000014272-23-000040 · wf-form4_167547007914465.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,617.356 Underlying: Common Stock, $0.10 par value · 2,807.806 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:48 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantRestricted Stock Units · Derivative | 20,395 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-001116 · doc4.xml · derivative · entry 2 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,395 Underlying: Common stock, par value $0.01 per share · 20,395 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock. F3 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. F3 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. F3 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025. Read SEC document |
| January 04, 2023 Filed Jan 6, 2023 01:48 UTC | GE HealthCare Technologies Inc. GEHC · Entity 1711 | GrantEmployee Stock Option (right to buy) · Derivative | 89,023 | Not disclosed Strike: $65.39 | Not disclosed |
DisclosureSEC source: 0000899243-23-001116 · doc4.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,023 Underlying: Common stock, par value $0.01 per share · 89,023 shares Expires 2032-03-01 F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will become exercisable on March 1, 2024 and 50% will become exercisable on March 1, 2025. F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will become exercisable on March 1, 2024 and 50% will become exercisable on March 1, 2025. Read SEC document |
| December 31, 2022 Filed Jan 4, 2023 22:25 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 469.076 | $71.95 | $33,750.02 |
DisclosureSEC source: 0000014272-23-000015 · wf-form4_167287108502903.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,485.576 Underlying: Common Stock, $0.10 par value · 469.076 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| September 30, 2022 Filed Oct 5, 2022 01:01 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 474.75 | $71.09 | $33,749.98 |
DisclosureSEC source: 0000014272-22-000184 · wf-form4_166493160415034.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,740.311 Underlying: Common Stock, $0.10 par value · 474.75 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| June 30, 2022 Filed Jul 5, 2022 20:31 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 438.312 | $77.00 | $33,750.02 |
DisclosureSEC source: 0000014272-22-000161 · wf-form4_165705304407453.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,979.645 Underlying: Common Stock, $0.10 par value · 438.312 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:14 UTC | BRISTOL MYERS SQUIBB CO BMY · Entity 1662 | GrantDeferred Share Units · Derivative | 462.139 | $73.03 | $33,750.01 |
DisclosureSEC source: 0000014272-22-000105 · wf-form4_164911043169891.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,266.108 Underlying: Common Stock, $0.10 par value · 462.139 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.